Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000827871-15-000031
Filing Date
2015-05-15
Accepted
2015-05-15 16:25:01
Documents
12
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q egrx_q1x2015new.htm 10-Q 717136
2 EXHIBIT 10.2 doc_116842003xvx2xcephalon.htm EX-10.2 364036
3 EXHIBIT 10.3 doc_116846672xvx2xcephalon.htm EX-10.3 179249
4 EXHIBIT 31.1 exhibit311q12015new.htm EX-31.1 11102
5 EXHIBIT 31.2 exhibit312q12015new.htm EX-31.2 11082
6 EXHIBIT 32.1 exhibit321q12015new.htm EX-32.1 9217
  Complete submission text file 0000827871-15-000031.txt   4763750

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT egrx-20150331.xml EX-101.INS 516232
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT egrx-20150331.xsd EX-101.SCH 27989
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT egrx-20150331_cal.xml EX-101.CAL 44874
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT egrx-20150331_def.xml EX-101.DEF 115048
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT egrx-20150331_lab.xml EX-101.LAB 380071
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT egrx-20150331_pre.xml EX-101.PRE 204840
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36306 | Film No.: 15869900
SIC: 2834 Pharmaceutical Preparations